| 发明名称 |
PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMOURS THAT EXPRESS EGFR AND GANGLIOSIDE N-GLYCOLYL GM3 (NEUGCGM3). |
| 摘要 |
<p>The invention relates to pharmaceutical composition for the treatment of malignant tumours, in particular tumours that express EGFR and N-glycolyl GM3 ganglioside targets, in order to enhance the therapeutic effect produced individually by therapies against said targets. The pharmaceutical compositions of the invention comprise antibodies and/or vaccines against each of the targets. In addition, the invention relates to the methods used to apply the compositions of the invention.</p> |
| 申请公布号 |
MX2014007919(A) |
申请公布日期 |
2014.07.30 |
| 申请号 |
MX20140007919 |
申请日期 |
2012.12.04 |
| 申请人 |
CENTRO DE INMUNOLOGIA MOLECULAR |
发明人 |
MONTERO CASIMIRO, JOSÉ ENRIQUE;LEÓN MONZÓN, KALET;GONZÁLEZ PALOMO, ADYS;CARR PEREZ, ADRIANA;BLANCO SANTANA, RANCÉS;BARROSSO ALVAREZ, MARÍA DEL CARMEN;MACÍAS ABRAHAM, AMPARO EMILIA |
| 分类号 |
A61P35/00;A61K39/00;A61K39/395;C07K16/28;C07K16/42 |
主分类号 |
A61P35/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
